Abstract:OBJECTIVE To investigate the relationship between the expression of perforin in T-lymphocyte subsets and antituberculosis in mice vaccinated with bacillus calmette-guerin (BCG). METHODS 120 KM male mice were divided into a Control group (group C, n = 40, 20 each in group C1 or C2), a BCG vaccinated group (group B, n = 40, 20 each in group B1 or B2), a Tuberculosis group (TB group, n = 20), and a BT group, in which the mice were attacked by Mycobacterium tuberculosis H(37)Rv (MTB) after acquired immunity by vaccination with BCG (n = 20). Initially, mice in group B1, B2 and BT were vaccinated with BCG synchronously. Three month later, mice in group BT and TB were attacked by MTB synchronously. Samples of blood, lung, liver and spleen of mice in group C1 and B1 were collected at the same time. One month later again, Samples of blood, lung, liver and spleen of mice in group C2, B2, BT and TB were collected at the same time. Samples of blood were assayed for T-lymphocyte subsets expressing perforin (PFN(+)). The positive numbers of PFN(+) [CD(3)(+), CD(4)(+), CD(8)(+), CD(4)(+)CD(8)(+) double positive (CD(4)(+)CD(8)(+))] T lymphocytes and their percentages were assayed by flow cytometer. Specimens of lung, liver and spleen were examined for pathology and bacteriology. RESULTS All the mice in the TB group acquired tuberculosis and the mortality was 55% (11/20) within 1 month. There were no tuberculosis and no death in mice of C, B and BT groups during the observation period. The amount of PFN(+) CD(8)(+) T lymphocytes in B group [(5.9 ± 0.9) × 10(3)] was significantly higher than that in C group [(4.8 ± 0.8) × 10(3)] (F = 42.24, P < 0.01). The PFN(+) CD(8)(+)% in TB group [(5.6 ± 0.9)%] was significantly less than that in B group [(7.3 ± 1.1)%] (F = 35.51, P < 0.05). For Mice in the BT group, the amount of PFN(+) (CD(3)(+), CD(8)(+), CD(4)(+)CD(8)(+)) T lymphocytes [(20.1 ± 5.5) × 10(3), (8.7 ± 0.4) × 10(3), 72 ± 19] and their CD(3)(+)%, CD(8)(+)%, CD(4)(+)CD(8)(+)% [(23.3 ± 3.3)%, (10.7 ± 1.6)%, (0.084 ± 0.015)%] were all higher than those in the B group [(13.0 ± 3.2) × 10(3), (5.9 ± 0.9) × 10(3), 36 ± 5, (15.5 ± 1.7)%, (7.3 ± 1.1)%, (0.044 ± 0.007)%] or the C group [(11.1 ± 3.0) × 10(3), (4.8 ± 0.8) × 10(3), 30 ± 7, (14.9 ± 1.7)%, (6.7 ± 0.9)%, (0.040 ± 0.006)%] or the TB group [(12.6 ± 1.6) × 10(3), (5.0 ± 0.1) × 10(3), 31 ± 3, (14.0 ± 1.7)%, (5.6 ± 0.9)%, (0.035 ± 0.005)%] (F = 14.23 - 74.98, P < 0.01 or P < 0.05), and the CD(4)(+)/CD(8)(+) in BT group (0.54 ± 0.17) was significantly lower than that in C group (0.76 ± 0.22) (F = 4.54, P < 0.01). CONCLUSIONS Pre-vaccination with BCG increased PFN(+) CD(8)(+) T lymphocytes in the host. Acquired immunity by BCG vaccination can protect the host from attack by Mycobacterium tuberculosis. Increased PFN(+) (CD(3)(+), CD(8)(+), CD(4)(+)CD(8)(+)) T lymphocytes may be involved. The expression level of PFN by T lymphocytes may be an important marker for antituberculosis immunity.

[Correlation Between the Expression of Perforin in T-lymphocyte Subsets and Antituberculosis in Mice Vaccinated with Bacillus Calmette-Guerin].

[Analysis of T Lymphocyte Subsets and Their Expression of 4 Cytokines in Tuberculosis Mice].

Expression of IFN-γ,IL-4 and IL-17A in asthmatic mice vaccinated with BCG and HepB in neonatal period

The Relationship between Anti-tuberculosis Effect and CD4+CD8+ Double Positive (DP)T Lymphocytes Subset in the Rats with BCG Vaccine

Decreased expression of CD_4~+ T cells perforin in peripheral blood of patients with pulmonary tuberculosis

Immunotherapeutic Effects of BCG-Polysaccharide Nucleic Acid on Murine with Pulmnary Tuberculosis

The different influence of BCG vaccination to the treatment effect of rats with tuberculosis and to the peripheral blood T lymphocyte subset at different period

Enhanced Protective Efficacy Against Mycobacterium Tuberculosis Afforded by BCG Prime‐dna Boost Regimen in an Early Challenge Mouse Model is Associated with Increased Splenic Interleukin‐2‐producing CD4 T‐cell Frequency Post‐vaccination

Impact of BCG Vaccine on Anti-tuberculosis and CD4+ CD8+ Double Positive T Lymphocyte Subset in Rats

Effects of Bacillus Calmette Guerin-Polysaccharide nucleic acid on expression of interferon-gamma, tumor necrosis factor-alpha and interleukin-10 mRNA in peripheral blood mononuclear cells from patients with pulmonary tuberculosis

The Significance of T Cell Subsets on the Peripheral Blood of Tuberculosis Infection Mice

Immune Correlates of Disseminated BCG Infection in IL12RB1-Deficient Mice

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells

Experimental Research of the Relationship Between Lung Pathological Changes and Cell Immunity of Tuberculosis Infection

Vitamin D deficiency affects the immunity against Mycobacterium tuberculosis infection in mice

The effect of bacillus Calmette-guerin vaccination and PPD on CD4~+ CD25~+ regulatory T cells and the lung pathology in a murine model of asthma

The Effects of Immunity Induced by BCG Priming and Tuberculosis Fusion Protein AMM Vaccine Boosting

The role of lymphocyte subsets in preventing tuberculosis following intravenous vaccination with BCG

Expression and Clinical Significance of B and T Lymphocyte Attenuator on CD4+ and CD8+ T Cells from Patients with Pulmonary Tuberculosis.

The Value of Effector T Cells in Patients with Tuberculous Meningitis and Pulmonary Tuberculosis by IFN-γenzyme-linked Immunospot Assay

Lung IL-17A-Producing CD4+ T Cells Correlate with Protection after Intrapulmonary Vaccination with Differentially Adjuvanted Tuberculosis Vaccines